Reply to sarcopenia is more than simply documenting low skeletal muscle mass

Author： Tollefson Matthew K.   Psutka Sarah P.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|1|159-160

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.1, 2015-01, pp. : 159-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sarcopenia is more than simply documenting low skeletal muscle mass

By Cintosun Umit   Tasci Ilker   Binay Safer Vildan   Safer Umut  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 159-159

Blackwell Publishing

Access to resources Recommend Favorite

Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle

By Lynch Gordon S  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2002-01 ,pp. : 11-27

Informa Healthcare

Access to resources Recommend Favorite

More muscle pain/weakness with raltegravir than darunavir

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

No vasodilator response to low-dose heparin in the forearm skeletal-muscle vascular bed

By Abbink Evertine   de Galan Bastiaan   van Ginneken Egidia   van Rosendaal Aarnout   Smits Paul  

European Journal of Clinical Pharmacology, Vol. 58, Iss. 1, 2002-04 ,pp. : 7-10

Springer Publishing Company

Access to resources Recommend Favorite

Low skeletal muscle is associated with toxicity in patients included in phase I trials

By Cousin Sophie   Hollebecque A.   Koscielny S.   Mir O.   Varga A.   Baracos V.   Soria J.   Antoun S.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 382-387

Springer Publishing Company

Access to resources Recommend Favorite